Know-how

Since its inception, Technogenetics has developed and produced reagents for the determination of antibodies to many infectious diseases. Its specific know-how in the area of endocrinology and biotechnologies, it has allowed the company to increase its research efforts and improve its manufacturing expertise.

Since the early 1980s, Technogenetics has developed and produced reagents for determining the antibody profile of infectious diseases, such as the TORCH complex and sexually transmitted diseases. In the 1990s, thanks to specific expertise in the sectors of endocrinology and biotechnologies, Technogenetics further increased its research efforts, launching interesting new development projects.

These included specific in vitro tests for the measurement of free fractions of thyroid hormones (TSH, FT3, FT4) using the Liso-phase method. Patented in 1997, this method was considered a standard worldwide for the diagnosis of thyroid disorders. Today, thanks to innovative technologies such as the use of magnetic particles with chemiluminescent tracer, Technogenetics engages in complex and ambitious challenges with the aim of offering the market increasingly efficient and advanced diagnostic solutions.

Technogenetics' well-established experience in the development and production of diagnostic kits resulted in the production in its R&D laboratories of a full line of new-generation analytes for autoimmune and infectious diseases: the TGS TA line. This product line, which is constantly updated, is run on a highly automated random access system, and can optimize the laboratory's diagnostic process without affecting quality, reproducibility of results and management of resources and processing times. In addition, the CE marking attests to the performance of and compliance with a complex series of procedures, to which in vitro medical-diagnostic devices must strictly conform.